(Biotech) You know I had a chance to hear a
presentation from Avax a few weeks ago, but
passed it up to listen to Ribozyme which was
scheduled for the same time slot. Those
Informed Investors forums certainly do not
have enough information to make solid judgements,
but I have to say, good or bad, they do have
at least a partial influence. fwiw, I was
impressed with two CEOs, Gail Maderis of
Genzyme Molecular Oncology (I call it Gizzmo)
and H. Stewart Parker of TGEN. Corixa and
Supergen were also very good, less information,
but plenty of pizzaz.
The only stock that has been doing particularly
well off that II forum, that I'm aware of, and
it is probably just coincidence, is CTIC, of course
I sold it awhile ago. Ha--shows you what I know!
I'd just go over to the older avxt thread and ask
Chirodoc what his current thoughts are.
My cancer vaccine stock is Gizzmo, totally missed
out on BIOM, oh well. I'm waiting on a letter from
gzmo, for now I am in for a small investment
because it's trending up nicely and it may also be
a pretty good play on genomics, but I wont load up
til I hear from investor relations (maybe by that
time Gizzmo will be a ten dollar stock, oh well).
To tell you the truth, if the VD model biotech
portfolio is up >200% for the year, and you now
know that my return is less than that (~160%,
varies a lot depending on where ariaw trade,
eeek) then you might as well just tag along side
the biotech guys here on SI, nipping at their
heels. They have been very kind to me--so long
as I don't overdo my solicitations for free
advice and they're a huge asset to the membership
of Silicon Investor. If I'd followed their enthusiasm
on Celgene and Neurocrine, and their many cautions
on Ariad (before that company fixed the toxic)
I'd actually be beating the model portfolio! |
